Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevinkumar Kansagra

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Human Vaccines & Immunotherapeutics|August 26, 2025
An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participantsSanjay Vasant Mankar, Chintan Patel, Abhishek Chavan, et al.
Experimental Neurology|February 6, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Human Vaccines & Immunotherapeutics|August 26, 2025
An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participantsSanjay Vasant Mankar, Chintan Patel, Abhishek Chavan, et al.
Experimental Neurology|February 6, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.
Pageof 3